Search Results
Apr 13, 2026, 09:00 ET Исследование DOORwaY90 компании Sirtex Medical демонстрирует 100% локальный контроль опухоли с помощью SIR-Spheres®, устанавливая новый ориентир в Y-90 для ГЦК
www.sirtex.com.APM-US-001-04-26Логотип —
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET 서텍스 메디컬의 DOORwaY90 시험, SIR-Spheres®로 100% 국소 종양 제어 입증하며 HCC 치료용 Y-90의 새로운 기준 제시
www.sirtex.com에서 확인할 수 있다.APM-US-001-04-26로고 -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Štúdia DOORwaY90 spoločnosti Sirtex Medical preukazuje 100 % lokálnu kontrolu nádoru pomocou SIR-Spheres®, čím stanovuje nový štandard pri liečbe Y-90 hepatocelulárneho karcinómu
www.sirtex.com.APM-US-001-04-26Logo:
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Studie DOORwaY90 společnosti Sirtex Medical prokázala stoprocentní lokální kontrolu nádoru pomocí SIR-Spheres® a stanovila tak nový standard v léčbě HCC pomocí Y-90
www.sirtex.com.APM-US-001-04-26Logo -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Studi DOORwaY90 dari Sirtex Medical Mendemonstrasikan Kontrol Tumor Lokal 100% dengan SIR-Spheres®, Menetapkan Tolok Ukur Baru di Y-90 untuk HCC
www.sirtex.com.APM-US-001-04-26Logo -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Die DOORwaY90-Studie von Sirtex Medical belegt eine 100-prozentige lokale Tumorkontrolle mit SIR-Spheres® und setzt damit neue Maßstäbe bei der Y-90-Therapie für HCC
www.sirtex.com.APM-US-001-04-26Logo –
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET O estudo DOORwaY90 da Sirtex Medical demonstra 100% de controle tumoral local com SIR-Spheres®, estabelecendo um novo padrão de referência para o Y-90 no tratamento do CHC
www.sirtex.com.APM-US-001-04-26Logotipo -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET El estudio DOORwaY90 de Sirtex Medical demuestra un control tumoral local del 100 % con SIR-Spheres®
www.sirtex.com.APM-US-001-04-26Logo -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET El ensayo clínico DOORwaY90 de Sirtex Medical demuestra controlar en un 100 % los tumores locales con las microesferas SIR-Spheres®, lo que establece un nuevo referente en el tratamiento con Y-90 para el carcinoma hepatocelular
www.sirtex.com.APM-US-001-04-26Logotipo -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET L'étude DOORwaY90 de Sirtex Medical démontre un contrôle local de la tumeur de 100 % avec SIR-Spheres®, établissant ainsi une nouvelle référence pour l'Y-90 dans le traitement du CHC
www.sirtex.com.APM-US-001-04-26Logo -
More news about: Sirtex Medical Inc.
Apr 13, 2026, 09:00 ET Nghiên Cứu DOORwaY90 của Sirtex Medical Chứng Minh Khả Năng Kiểm Soát Khối U Tại Chỗ đạt 100% với SIR-Spheres®, Thiết Lập Chuẩn Mực Mới Trong Điều Trị HCC bằng Y-90
www.sirtex.com.APM-US-001-04-26Logo -
More news about: Sirtex Medical Inc.
Apr 12, 2026, 16:56 ET METLEN Energy & Metals : résultats financiers 2025
-6401. Mesures de performance non PCGR/alternatives (APM)2. Résultat après impôts après minoritésLe chiffre d'affaires a atteint 7 107 millions d'euros en 2025, soit une
More news about: METLEN Energy & Metals PLC
Apr 10, 2026, 00:20 ET METLEN Energy & Metals: Geschäftsergebnisse 2025
-6401. Nicht-GAAP-Kennzahlen/Alternative Leistungskennzahlen (Alternative Performance Measures, APM)2. Gewinn nach Steuern und Anteilen anderer GesellschafterDer Umsatz belief sich im Jahr 2025 auf 7.107 Millionen Euro,
More news about: METLEN Energy & Metals PLC
Apr 09, 2026, 11:20 ET METLEN Energy & Metals: resultados financieros de 2025
-6401. no GAAP/medidas de rendimiento alternativas (APM)2. Ganancias después de impuestos después de las minoríasLos ingresos alcanzaron los 7.107 millones de euros en
More news about: METLEN Energy & Metals PLC
Apr 09, 2026, 05:00 ET METLEN Energy & Metals: 2025 Financial Results
-6401. non-GAAP/Alternative Performance Measures (APM)2. Earnings after Tax after minoritiesRevenue reached €7,107 million in 2025, up 25% from €5,683 million in 2024,
More news about: METLEN Energy & Metals PLC
Apr 09, 2026, 04:57 ET METLEN Energy & Metals: 2025 Financial Results
-6401. non-GAAP/Alternative Performance Measures (APM)2. Earnings after Tax after minoritiesRevenue reached €7,107 million in 2025, up 25% from €5,683 million in 2024,
More news about: METLEN Energy & Metals PLC
Apr 08, 2026, 11:55 ET AMERICAN PUBLIC MEDIA ANNOUNCES NEW DIGITAL AUDIO ADVERTISING NETWORK
americanpublicmedia.orgAbout American Public Media American Public Media® (APM) is the national programming and distribution division of Minnesota Public Radio® and reaches over 15 million listeners weekly across 1,000 public radio stations. APM is one of the largest producers and distributors of public radio
More news about: American Public Media
Mar 18, 2026, 07:59 ET Venatus Delivers 5x Higher Video Ad Attention by Activating Audiences "In the Zone", Lumen Research Finds
videoGenerate up to five times higher Attention Per 1,000 Impressions (APM) than standard digital video benchmarks These gains reflect measurable shifts across Lumen's core attention metrics of % Viewed, Average View Time, and APM (Attention per Mille), demonstrating that Venatus does not simply
More news about: Venatus
Mar 17, 2026, 10:15 ET UNIBIRD Launches N200M Visual Navigation Module for GPS-Denied Environments
generationPrice remains $399—about one-twentieth the cost of traditional fiber-optic inertial systems—with plug-and-play compatibility for PX4 and APM controllers.Stable Navigation Without GPSThe N200M Visual Navigation Module is designed to deliver enhanced performance compared
More news about: UNIBIRD
Mar 16, 2026, 03:15 ET OCI Global Reports H2 2025 and FY 2025 Unaudited Results
EBITDAAdjusted EBITDAAdjusted EBITDA is an Alternative Performance Measure (APM) that intends to give a clear reflection of the underlying performance of OCI's operations. The main APM adjustments in the second half of 2025 and 2024 relate to:Commodity hedge
More news about: OCI Global
Mar 16, 2026, 03:07 ET OCI Global Reports H2 2025 and FY 2025 Unaudited Results
EBITDAAdjusted EBITDAAdjusted EBITDA is an Alternative Performance Measure (APM) that intends to give a clear reflection of the underlying performance of OCI's operations. The main APM adjustments in the second half of 2025 and 2024 relate to:Commodity hedge
More news about: OCI Global
Feb 26, 2026, 08:00 ET Behrman Capital Sells Portfolio Company Waterline Renewal Technologies to Azuria Water Solutions, a New Mountain Capital Company
property damage. Waterline's diverse portfolio includes a range of patented solutions delivered through its industry-leading brands, including Perma-Liner, APM, LMK Technologies, and LightRay.Dave Williams, CEO of Waterline, said: "On behalf of everyone at Waterline, I'd like to thank the Behrman Capital
More news about: Behrman Capital
Feb 26, 2026, 07:12 ET Maersk Deepens Saudi Footprint With Stake in Jeddah Terminal as Red Sea Trade Gains Strategic Weight
JEDDAH, Saudi Arabia, Feb. 26, 2026 /PRNewswire/ -- Saudi Ports Authority announced that APM Terminals, a wholly owned subsidiary of A.P. Moller–Maersk, has acquired a 37.5% stake in the South Container Terminal at Jeddah Islamic Port, reinforcing
More news about: Mawani
Feb 23, 2026, 16:30 ET Chemours' Gerardo Familiar Appointed to SEMI North America Advisory Board
/PRNewswire/ --The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced that Gerardo Familiar, President of the company's APM business, has been appointed to the
More news about: The Chemours Company
Feb 19, 2026, 16:38 ET The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
However, as a result of short-term cyclical end market headwinds experienced in our APM business, we elected to prioritize cash flow, leading to strong cash generation in the quarter. In connection with this approach APM incurred a sizable non-cash inventory charge and unfavorable product mix driving our
More news about: The Chemours Company